EMERGINGDX INC — Department of Defense SBIR: DHA SBIR PH II TOPIC DHA23B-001, MEDICAL R&D CONTRACT FROM PROPOSAL H2-0793, TITLE: AUTOMA

EMERGINGDX INC — SBIR award from Department of Defense.

SBIR award competitive context

  • Public SBIR obligation from Department of Defense to EMERGINGDX INC. Use agency + tech-domain links below to map the broader competitive field.
  • Obligated amount $1,299,989 is consistent with substantial Phase II-scale effort; compare to related awards from the same agency.
  • Tagged technology areas: Human Performance & Medical. Follow those hubs for open topics and peer winners in the same cluster.

Informational capture context from public federal data — not legal or bid advice.

Summary

EmergingDx Inc received nearly $1.3 million from the Defense Health Agency for a Phase II SBIR project. The award funds development of an automated platform to detect circulating and exosomal miRNAs for medical diagnostics and research.

Amount
$1,299,989
Agency
Department of Defense · Defense Health Agency
Program / Phase
SBIR
NAICS
541715 · RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT NANOTECHNOLOGY AND BIOTECHNOLOGY)
Place of performance
MA
Period
2024-09-20 → 2027-01-19

Technology domains

Human Performance & Medical

Description

DHA SBIR PH II TOPIC DHA23B-001, MEDICAL R&D CONTRACT FROM PROPOSAL H2-0793, TITLE: AUTOMATED DETECTION PLATFORM OF CIRCULATING AND EXOSOMAL MIRNAS

View on USASpending.gov ↗